期刊文献+

系统性红斑狼疮女性患者血清25(OH)D_3水平测定及其与骨密度关系的研究 被引量:2

Serum vitamin D level in patients with systemic lupus erythematosus and its relationship with bone mineral density
下载PDF
导出
摘要 目的横断面观察系统性红斑狼疮(SLE)女性患者血清25(OH)D3的水平,统计其不足和缺乏的发生率;分析SLE患者血清25(OH)D3水平不足和缺乏的相关影响因素;研究血清中维生素D水平与疾病活动度(SLEDAI)、骨密度(BMD)等之间的相关性。方法选取无锡市第二人民医院2009年09月~2011年03月风湿科门诊及住院SLE未孕女性患者106例作为病例组,搜集患者资料;选取73例健康体检者作为对照组,采用酶联免疫法测定外周血血清中25(OH)D3的浓度,采用双能X线测量SLE组人员的BMD,进行各因素间相关分析。结果 106例SLE患者血清25(OH)D3水平较73例健康对照组显著低下(t=-10.422,P<0.001),影响因素有使用糖皮质激素、糖皮质激素使用剂量、肾脏受累。血清25(OH)D3水平与疾病活动度评分间有负相关(r=-0.602,P=0.023)。未接受糖皮质激素治疗的SLE患者血清25(OH)D3水平与BMD间有统计学相关性(r=0.178,P=0.012),而接受糖皮质激素患者两者之间无统计学相关性。结论女性SLE患者血清25(OH)D3水平较健康对照组显著低下,使用糖皮质激素、激素剂量、肾脏受累是其显著的影响因素;血清25(OH)D3水平与疾病活动度相关;未接受糖皮质激素治疗SLE患者血清25(OH)D3水平与BMD间有相关性。血清25(OH)D3的测定可为预测疾病活动程度、早期干预提供依据。 Objective The objective of this study was To determine the serum level of vitamin D in patients with systemic lupus erythematosus(SLE),to calculate the incidence of its deficiency and the influential factors,and to study the relationship among serum 25(OH)D3 level,SLE activity index(SLEDAI),and bone mineral density(BMD).Methods Datas were collected from 106 non-pregnant female SLE patients,who were in outdoor and indoor patient department in the Second People's Hospital of Wuxi,from September 2009 to March 2011.Seventy-three healthy people were chosen as control.Peripheral serum 25(OH)D3 level was determined using ELISA method.BMD of SLE patients was measured with DEXA.Results Factors were analyzed.Results The mean 25(OH)D3 level in 106 SLE patients(22.37±6.74ng/ml) was significantly lower than in 73 controls(33.90±8.08 ng/ml,t=-10.422,P0.001).The related factors included the use of glucocorticoid,the dose of glucocorticoid,and the renal damage.Serum 25(OH)D3 level was negatively correlated with SLEDAI(r=-0.602,P=0.023).Serum 25(OH)D3 level in SLE patients who were not treated with glucocorticoid was associated with BMD status(r=0.178,P=0.012),but not in patients who were treated with glucocorticoid.Conclusion Vitamin D level is low in patients with SLE than in controls.The use and dose of glucocorticoid and the renal damage are significant influential factors.The vitamin D level was also associated with disease activity.25(OH)D3 in SLE patients without using glucocorticoid is correlated with BMD status.Serum 25(OH)D3 measurement can be use to predict the disease activity and to provide evidence for early intervention.
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2012年第4期313-316,共4页 Chinese Journal of Osteoporosis
基金 2011年无锡市科技立项指导项目(CSZ01010)
关键词 系统性红斑狼疮 血清25(OH)D3 酶联免疫法 疾病活动度 骨密度 SLE Serum 25(OH)D3 Enzyme-linked immunosorbent assay Diseases activity index BMD
  • 相关文献

参考文献19

  • 1Arnson Y,Amital H,Shoenfeld Y.Vitamin D and autoimmunity:new etiological and therapeutical considerations.Ann Rheum Dis,2007,66(9):1137-1142.
  • 2Hochberg MC.Updating the American College of Rheumatologyrevised criteria for the classification of systemic lupuserythematosus.Arthritis Rheum,1997,40(9):1725.
  • 3Siminoski K,Leslie WD,Frame H,et al.Canadian Association ofRadiologists.Recommendations for bone mineral density reportingin Canada.Can Assoc Radiol J,2005,56(3):178-188.
  • 4Holick MF.Vitamin D deficiency.N Engl J Med,2007,357(10):266-281.
  • 5Kamen DL,Cooper GS,Bouali H,et al.Vitamin D deficiency insystemic lupus erythematosus.Autoimmun Rev,2006,5(2):114-117.
  • 6Thudi A,Yin S,Wandstrat AE,et al.Vitamin D levels anddisease status in Texas patients with systemic lupuserythematosus.Am J Med Sci,2008,335(2):99-104.
  • 7Ruiz-Irastorza G,Egurbide MV,Olivares N.Vitamin D deficiencyin systemic lupus erythematosus:prevalence,predictors andclinical consequences.Rheumatology,2008,47(6):920-923.
  • 8郑一君,胡大伟,陈盛,谈裔,鲍春德,夏佳靖,敖文,袁敏.系统性红斑狼疮初发患者外周血中维生素D及其受体mRNA的水平和意义[J].中华风湿病学杂志,2009,13(9):595-598. 被引量:7
  • 9Teichmann J,Lange U,Stracke H,et al.Bone metabolismandbonemineral density of systemic lupus erythematosus at the time ofdiagnosis.Rheumatol Int,1999,18(4):137-140.
  • 10G.Ruiz-Irastorza,M.V.Egurbide,N.Olivares,et al.Vitamin Ddeficiency in systemic lupus erythematosus:prevalence,predictorsand clinical consequences.Rheumatology,2008,47(6):920-923.

二级参考文献12

  • 1Borba VZ, Vieira JG, Kasamatsu T, et al, Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int, 2008, 4: 1433-2965.
  • 2Kalla AA, Fataar AB, Jessop S J, et al. Loss of trabecular bone mineral density in systemic lupus erythematosus. S Afr Med J, 1993, 36: 1726-1734.
  • 3Sen D, Keen RW. Osteoporosis in systemic lupus erythematosus: prevention and treatment. Lupus, 2001, 10: 227-232.
  • 4Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol, 2005, 289: 8-28.
  • 5Abe E, Miyaura C, Sakagami H,et al. Differentiation of mouse myeloid leukemia cells induced by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA, 1981, 78: 4990-4994.
  • 6Cutolo M, Otsa K. Vitamin D, immunity and lupus. Lupus, 2008, 17: 6-10.
  • 7Chen S, Sims GP, Chen XX,et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol, 2007, 179: 1634-1647.
  • 8Kamen DL, Cooper GS, Bouali H, et al. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev, 2006, 5: 114- 117.
  • 9Lee C, Almagor O, Dunlop DD, et al. Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving eorticosteroids. Rheumatology, 2006, 45: 53-60.
  • 10Li EK, Tam LS, Young RP, et al. Loss of bone mineral density in Chinese premenopausal women with systemic lupus erythematosus treated with corticosteroids. Br J Rheumatol, 1998, 37: 405--410.

共引文献6

同被引文献50

  • 1刘爱华,张颖,王钱,黄慈波.老年系统性红斑狼疮[J].中国临床保健杂志,2005,8(3):276-279. 被引量:8
  • 2王文姬,陈楠.活性维生素D_3与肾脏病[J].肾脏病与透析肾移植杂志,2006,15(3):262-265. 被引量:12
  • 3李姝玉,胡大伟.系统性红斑狼疮患者骨质疏松的相关因素[J].中国骨质疏松杂志,2007,13(6):447-450. 被引量:5
  • 4Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune sys- tem[J]. Arch Biochem Biophys, 2000,374 (2) : 334-338.
  • 5Hochberg MC. Updating the American College of Rheuma- tology revised criteria for the classification of systemic lu- pus erythematosus[J]. Arthritis Rheum1997;40(9): 1725.
  • 6Hamza RT,Awwad KS,Ali MK,et al. Reduced serum con- centrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: relation to disease ac- tivity[J]. Med Sci Monit, 2011,17 (12) : CR711-718.
  • 7Ben-Zvi I,Aranow C, Mackay M,et al. The impact of vi- tamin D on dendritic cell function in patients with sys- temic lupus erythematosus[J]. PLo S One,2010,5(2):e9193.
  • 8Penna G,Adorini L.1 Alpha,25-dihydroxyvitamin D3 in- hibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell acti- vation[J]. J Immunol, 2000,164(5) : 2405-2411.
  • 9Chen S,Sims GP,Chen XX,et al. Modulatory effects of 1,25-dihydroxy vitamin D3 on human B cell differentia- tion[J]. J Immunol,2007,179(3) ; 1634-1647.
  • 10Thudi A, Yin S, Wandstrat AE, et al. Vitamin D levels and disease status in Texas patients with systemic lupus ery- thematosus[J]. Am J Med Sci, 2008,335 (2) : 99-104.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部